Literature DB >> 14670614

Peroxisome proliferator-activated receptors (PPARs) and associated transcription factors in colon cancer: reduced expression of PPARgamma-coactivator 1 (PGC-1).

Jonas Feilchenfeldt1, Marie Anne Bründler, Claudio Soravia, Martin Tötsch, Christoph A Meier.   

Abstract

Peroxisome proliferator-activated receptors (PPARs) alpha,beta/delta and gamma are fatty acid sensitive transcription factors that have been implicated in colorectal cancer. To better understand their role, we studied the expression levels of all PPAR-isoforms and transcriptional partners such as the retinoid X receptor alpha (RXRalpha) and PPARgamma-coactivator-1 (PGC-1) by means of real-time PCR in 17 patients with colon cancer. While a heterogeneous pattern was observed for the expression level of the PPAR-isoforms alpha,beta/delta and gamma, the coactivator PGC-1 was significantly decreased in 15 of 17 tumors. Taken together our data suggest that the transcriptional activity of PPARgamma may not only be decreased by mutation but also by downregulation of the coactivator PGC-1 of PPARgamma.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14670614     DOI: 10.1016/j.canlet.2003.08.024

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  48 in total

Review 1.  Reversible acetylation of PGC-1: connecting energy sensors and effectors to guarantee metabolic flexibility.

Authors:  E H Jeninga; K Schoonjans; J Auwerx
Journal:  Oncogene       Date:  2010-06-07       Impact factor: 9.867

Review 2.  The diverse role of the PPARγ coactivator 1 family of transcriptional coactivators in cancer.

Authors:  Geoffrey D Girnun
Journal:  Semin Cell Dev Biol       Date:  2012-01-21       Impact factor: 7.727

Review 3.  The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention.

Authors:  Jeffrey M Peters; Yatrik M Shah; Frank J Gonzalez
Journal:  Nat Rev Cancer       Date:  2012-02-09       Impact factor: 60.716

Review 4.  NO control of mitochondrial function in normal and transformed cells.

Authors:  Celia H Tengan; Carlos T Moraes
Journal:  Biochim Biophys Acta Bioenerg       Date:  2017-02-16       Impact factor: 3.991

5.  Intestinal PPARα Protects Against Colon Carcinogenesis via Regulation of Methyltransferases DNMT1 and PRMT6.

Authors:  Yuhong Luo; Cen Xie; Chad N Brocker; Jie Fan; Xuan Wu; Lijin Feng; Qiong Wang; Jie Zhao; Dasheng Lu; Mayank Tandon; Maggie Cam; Kristopher W Krausz; Weiwei Liu; Frank J Gonzalez
Journal:  Gastroenterology       Date:  2019-05-30       Impact factor: 22.682

Review 6.  Role of retinoids in the prevention and treatment of colorectal cancer.

Authors:  Catherine C Applegate; Michelle A Lane
Journal:  World J Gastrointest Oncol       Date:  2015-10-15

7.  Metastasis suppressor KISS1 seems to reverse the Warburg effect by enhancing mitochondrial biogenesis.

Authors:  Wen Liu; Benjamin H Beck; Kedar S Vaidya; Kevin T Nash; Kyle P Feeley; Scott W Ballinger; Keke M Pounds; Warren L Denning; Anne R Diers; Aimee Landar; Animesh Dhar; Tomoo Iwakuma; Danny R Welch
Journal:  Cancer Res       Date:  2013-12-18       Impact factor: 12.701

8.  Direct link between metabolic regulation and the heat-shock response through the transcriptional regulator PGC-1α.

Authors:  Neri Minsky; Robert G Roeder
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-05       Impact factor: 11.205

9.  Expression of PPARγ and PTEN in human colorectal cancer: An immunohistochemical study using tissue microarray methodology.

Authors:  Mao Song Lin; Jun Xing Huang; Wei Chang Chen; Bao Feng Zhang; Jing Fang; Qiong Zhou; Ying Hu; Heng Jun Gao
Journal:  Oncol Lett       Date:  2011-09-06       Impact factor: 2.967

Review 10.  Targeting peroxisome proliferator-activated receptor-β/δ in colon cancer: how to aim?

Authors:  Min Xu; Xiangsheng Zuo; Imad Shureiqi
Journal:  Biochem Pharmacol       Date:  2012-10-04       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.